Ayush body joins ASCI against misleading ads

CCIM has issued an advisory to all state councils to take action against such advertisers

Patanjali had been pulled up by ASCI earlier for misleading ads
Patanjali had been pulled up by ASCI earlier for misleading ads
Viveat Susan Pinto Mumbai
Last Updated : Mar 15 2017 | 12:50 AM IST

Don't want to miss the best from Business Standard?

The Advertising Standards Council of India (ASCI), the country’s apex ad regulator, has got a shot in the arm in its fight against misleading health care ads. The Central Council of Indian Medicine (CCIM), a statutory body under the Union ministry of Ayush, has issued an advisory to all state boards and councils to take action against those making false and misleading health care claims.

The move comes as ASCI and the Ayush ministry get down to monitoring print and television ads of ayurvedic, unani, homeopathic and yoga & naturopathic practitioners as part of a memorandum of understanding (MoU) signed this January.

The MoU will see ASCI act as an executive arm of the Ayush ministry, helping the latter weed out misleading ads. Once ASCI identifies a false ad, it will warn the advertiser to either remove the ad or modify it. In case of non-compliance, ASCI will write to the Ayush ministry or the state licensing authority, which will then take appropriate action.

These steps are significant, say experts, since consumers in the past few years have gravitated towards herbal and ayurvedic products and medicines. And proponents of these products such as Ramdev, co-founder of Patanjali Ayurved, are getting increasingly aggressive. 

Patanjali has been pulled up by ASCI earlier for misleading ads, which is currently being challenged in court. ASCI officials have declined to comment, saying the matter is sub-judice.

The CCIM advisory has asked state boards and councils to report ads that violate the Indian medicine regulations of 1982. This is expected to add one more layer to the monitoring already initiated by ASCI. 

“With state councils asked to report violations, it will help in curbing misleading claims made by practitioners of the Indian system of medicine,” Shweta Purandare, secretary general, ASCI, said.

The ad regulator has repeatedly highlighted the menace posed by indigenous doctors who make arbitrary claims of health and medical benefits with no scientific evidence backing them.

Of the complaints that ASCI receives regularly, those in education, health care and food & beverages are among the top three. While ASCI has an MoU with the Food Safety and Standards Authority of India for clamping down on errant food ads, it is also working closely, say sources, to stitch up an arrangement to monitor education ads.

ASCI, in its drive to increase awareness of the issue of quacks and false doctors, has asked consumers to complain against them. Those who are uncertain of the credentials of a doctor can reach out to ASCI who will then step in and direct the matter to the relevant authorities.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story